Key facts
- This page summarizes Eric Eugene Esser's Form 4 filing for Telesis Bio Inc. (TBIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Mar 2024, 18:40.
Eric Eugene Esser - 22 Jun 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)
- Reporting relationship
- President & COO
- Issuer ticker
- TBIO
- Reported as of
- 22 Jun 2023
- Net transaction value
- -$1,764
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2024, 18:40:25 UTC
- Prior SEC filing
- 08 Aug 2022
- Next SEC filing
- 19 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rob Cutler, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Eugene Esser filed Form 4 for Telesis Bio Inc. (TBIO) on 05 Mar 2024.
Change
- Previous filing in this sequence was filed on 08 Aug 2022.
- Current net transaction value: -$1,764.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBIO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +32,600
- Change %
- Price
- $0.000000
- Shares after
- 32,600
- Date
- 22 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
TBIO
transaction
Common Stock
Tax liability
- Transaction value
- $1,764
- Shares
- -3,340
- Change %
- -10%
- Price
- $0.5280
- Shares after
- 29,260
- Date
- 01 Mar 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TBIO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +263,600
- Change %
- Price
- $0.000000
- Shares after
- 263,600
- Date
- 22 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 263,600
- Exercise price
- $1.66
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 25% of the RSUs shall vest on each of March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027.
Footnote F2
Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
Footnote F3
Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter.